Results 231 to 240 of about 20,052 (248)

Semaglutide impacts skeletal muscle to a similar extent as caloric restriction in mice with diet‐induced obesity

The Journal of Physiology, EarlyView.
Abstract figure legend Four weeks of semaglutide treatment causes significant reductions in total body weight, fat mass, lean mass, and grip strength in mice with diet induced obesity. Mice treated with semaglutide lost a greater amount of total body weight and fat mass compared to mice fed fed a calorie matched diet.
S. Jeromson, B. Baranowski, M. Akcan, B. D. Waters, K. Eisner, A. Bellucci, S. Trang, A. Abolhassani, M. A. Tello‐Palencia, A. Schweitzer, B. Stefanska, C. J. Mitchell, David C. Wright   +12 more
wiley   +1 more source

Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections. [PDF]

Endosc Int Open
Li Z, Zhang S, Nie Y, Wang P, Liu B, Zhou B, Zhang N, Wang S, Chou S, Zhang L, Wang Z, Meng H.   +11 more
europepmc   +1 more source

A Delicate Balance

Journal of the American Geriatrics Society, EarlyView.
Ami Schattner
wiley   +1 more source

Sex‐specific metabolic responses to glucagon receptor agonism and modulation of the FGF21‐glucagon axis in female mice

The Journal of Physiology, EarlyView.
Abstract figure legend Therapies targeting the glucagon receptor are being explored for obesity treatment, yet most preclinical studies remain male biased. In this study, Merrild and Johansen et al. show that in diet‐induced obese wild‐type mice a long‐acting glucagon analogue (LA‐Gcg) elicits sexually dimorphic effects on weight loss, food intake ...
Christoffer Merrild, Valdemar Brimnes Ingemann Johansen, Christoffer Clemmensen, Pablo Ranea‐Robles   +3 more
wiley   +1 more source

Quality and reliability of semaglutide content on different Chinese short video platforms: a study focusing on side effects. [PDF]

Front Public Health
Song J, He X, Cui Z, Sun Y, Liu Y, Yu H, Li A, Jin M.   +7 more
europepmc   +1 more source

Pleural and Pericardial Effusions Associated with Semaglutide: A Case Report. [PDF]

Clin Pract Cases Emerg Med
Stark M, Valentini N.
europepmc   +1 more source

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023. [PDF]

Obesity (Silver Spring)
Adekunle OA, Le P, Boyer C, Gasoyan H, Gupta DY, Tran HT, Yue Y, Rothberg MB.   +7 more
europepmc   +1 more source

Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks. [PDF]

Perioper Med (Lond)
Merhavy ZI, Kowal Z, Spencer T, Trachuk AM, Aldanese A, Ahmed Z, Arsene C.   +6 more
europepmc   +1 more source

Sarcopenia considerations when prescribing glucagon-like peptide-1 agonists to older adults. [PDF]

Korean J Fam Med
Mohamad AA.
europepmc   +1 more source